Cargando…

Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal

Immunogenic cell death (ICD) is a well-established instigator of ‘anti-cancer vaccination-effect (AVE)’. ICD has shown considerable preclinical promise, yet there remain subset of cancer patients that fail to respond to clinically-applied ICD inducers. Non-responsiveness to ICD inducers could be exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garg, Abhishek D., Elsen, Sanne, Krysko, Dmitri V., Vandenabeele, Peter, de Witte, Peter, Agostinis, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694957/ https://www.ncbi.nlm.nih.gov/pubmed/26314964

Ejemplares similares

Correction: Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal
por: Garg, Abhishek D., et al.
Publicado: (2018)

The emergence of phox-ER stress induced immunogenic apoptosis
por: Garg, Abhishek D., et al.
Publicado: (2012)

Extracellular ATP and P(2)X(7) receptor exert context-specific immunogenic effects after immunogenic cancer cell death
por: Garg, A D, et al.
Publicado: (2016)

Diversifying the platinum-based chemotherapy toolkit for immunogenic cancer cell death
por: Garg, Abhishek D., et al.
Publicado: (2020)

Editorial: Immunogenic Cell Death in Cancer: From Benchside Research to Bedside Reality
por: Garg, Abhishek D., et al.
Publicado: (2016)

Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity
por: Garg, Abhishek D, et al.
Publicado: (2013)

Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
por: Adkins, Irena, et al.
Publicado: (2015)

Macrophages regulate the clearance of living cells by calreticulin
por: Krysko, Dmitri V., et al.
Publicado: (2018)

Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity
por: Dudek, Aleksandra M., et al.
Publicado: (2013)

Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
por: Decraene, Brecht, et al.
Publicado: (2022)

Immunogenic ferroptosis and where to find it?
por: Demuynck, Robin, et al.
Publicado: (2021)

Publisher Correction: Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
por: Decraene, Brecht, et al.
Publicado: (2022)

BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton
por: Maes, H, et al.
Publicado: (2014)

Chloroquine anticancer activity is mediated by autophagy-independent effects on the tumor vasculature
por: Maes, Hannelore, et al.
Publicado: (2015)

Necroptosis in Immuno-Oncology and Cancer Immunotherapy
por: Sprooten, Jenny, et al.
Publicado: (2020)

ATP Release from Dying Autophagic Cells and Their Phagocytosis Are Crucial for Inflammasome Activation in Macrophages
por: Ayna, Gizem, et al.
Publicado: (2012)

Size-Dependent Phagocytic Uptake and Immunogenicity of Gliadin Nanoparticles
por: Alqahtani, Mohammed S., et al.
Publicado: (2020)

In Vitro Veritas: From 2D Cultures to Organ-on-a-Chip Models to Study Immunogenic Cell Death in the Tumor Microenvironment
por: Krysko, Dmitri V., et al.
Publicado: (2022)

DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosis
por: Vedunova, Maria, et al.
Publicado: (2022)

Trial watch: chemotherapy-induced immunogenic cell death in oncology
por: Sprooten, Jenny, et al.
Publicado: (2023)

Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy
por: Catanzaro, Elena, et al.
Publicado: (2022)

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
por: Garg, Abhishek D., et al.
Publicado: (2015)

The “Yin and Yang” of Unfolded Protein Response in Cancer and Immunogenic Cell Death
por: Rufo, Nicole, et al.
Publicado: (2022)

Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
por: Schaaf, Marco B., et al.
Publicado: (2018)

Stress-induced inflammation evoked by immunogenic cell death is blunted by the IRE1α kinase inhibitor KIRA6 through HSP60 targeting
por: Rufo, Nicole, et al.
Publicado: (2021)

Many faces of DAMPs in cancer therapy
por: Krysko, O, et al.
Publicado: (2013)

Effect of LPS, dsRNA or interferons on the phagocytosis of dying cells or mycobacteria by macrophages
por: Vanzembergh, Frederic, et al.
Publicado: (2011)

Melanoma immunotherapy
por: Garg, Abhishek D., et al.
Publicado: (2015)

Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
por: Alzeibak, Razan, et al.
Publicado: (2021)

Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death
por: Turubanova, Victoria D., et al.
Publicado: (2021)

Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine
por: Turubanova, Victoria D., et al.
Publicado: (2019)

Drug-induced ciliogenesis in pancreatic cancer cells is facilitated by the secreted ATP-purinergic receptor signaling pathway
por: Khan, Niamat Ali, et al.
Publicado: (2017)

Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress
por: Garg, Abhishek D, et al.
Publicado: (2014)

Anticancer and Immunogenic Properties of Cardiac Glycosides
por: Schneider, Naira Fernanda Zanchett, et al.
Publicado: (2017)

Galectin-3 (MAC-2) Controls Microglia Phenotype Whether Amoeboid and Phagocytic or Branched and Non-phagocytic by Regulating the Cytoskeleton
por: Reichert, Fanny, et al.
Publicado: (2019)

Immunogenic cell death inducers as anticancer agents
por: Kepp, Oliver, et al.
Publicado: (2014)

Ferroptosis becomes immunogenic: implications for anticancer treatments
por: Tang, Daolin, et al.
Publicado: (2020)

Phagocytes
Publicado: (1891)

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells
por: Romano, Erminia, et al.
Publicado: (2018)

Correction: BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells
por: Romano, Erminia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c6778c6cga6vel44llu5esknfk